Clinical trials
Phase 4 Myeloproliferative Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2012 | 1 |
| 2022 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| PharmaEssentia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myeloproliferative Disorders | 4 |
| Blast Crisis | 1 |
| Blood Coagulation Disorders | 1 |
| Blood Platelet Disorders | 1 |
| Bone Marrow Diseases | 1 |
| Hematologic Neoplasms | 1 |
| Hemorrhagic Disorders | 1 |
| Leukemia, Lymphoid | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
| Lymphoma | 1 |
Trials
Showing 76 to 4 of 4. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.